---
figid: PMC12058482__fmolb-12-1564176-g003
figtitle: Molecular mechanisms of epithelial-mesenchymal transition
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC12058482
filename: fmolb-12-1564176-g003.jpg
figlink: /pmc/articles/PMC12058482/figure/F3/
number: F3
caption: The molecular mechanisms of epithelial-mesenchymal transition. Alveolar type
  2 (AT2) epithelial cells undergo epithelial-mesenchymal transition (EMT), transforming
  into myofibroblasts, with increased expression of N-cadherin, α-smooth muscle actin
  (α-SMA), fibronectin, and vimentin. Transforming growth factor-β (TGF-β), fibroblast
  growth factors (FGFs), epidermal growth factors (EGFs), and the Wnt/β-catenin signaling
  pathway can initiate EMT. EMT can also be initiated by extracellular transcription
  factors or activated signaling pathways. In the Smad-dependent pathway, activated
  TGF-β phosphorylates Smad 2/3 transcription factors in the cytoplasm, inducing the
  expression of target genes such as α-SMA and COL1A1. Non-Smad pathways such as the
  MAPK/ERK, TAK1/JNK, PI3K/AKT pathways, can also be activated to promote cytoskeletal
  remodeling and β-catenin nuclear translocation during the process of EMT
papertitle: Alveolar epithelial cell dysfunction and epithelial-mesenchymal transition
  in pulmonary fibrosis pathogenesis
reftext: Caopei Zheng, et al. Front Mol Biosci. 2025;12(NA).
year: '2025'
doi: 10.3389/fmolb.2025.1564176
journal_title: Frontiers in Molecular Biosciences
journal_nlm_ta: Front Mol Biosci
publisher_name: Frontiers Media SA
keywords: alveolar epithelial cell | epithelial-mesenchymal transition | molecular
  mechanisms | signaling pathways | pulmonary fibrosis
automl_pathway: 0.9478111
figid_alias: PMC12058482__F3
figtype: Figure
redirect_from: /figures/PMC12058482__F3
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC12058482__fmolb-12-1564176-g003.html
  '@type': Dataset
  description: The molecular mechanisms of epithelial-mesenchymal transition. Alveolar
    type 2 (AT2) epithelial cells undergo epithelial-mesenchymal transition (EMT),
    transforming into myofibroblasts, with increased expression of N-cadherin, α-smooth
    muscle actin (α-SMA), fibronectin, and vimentin. Transforming growth factor-β
    (TGF-β), fibroblast growth factors (FGFs), epidermal growth factors (EGFs), and
    the Wnt/β-catenin signaling pathway can initiate EMT. EMT can also be initiated
    by extracellular transcription factors or activated signaling pathways. In the
    Smad-dependent pathway, activated TGF-β phosphorylates Smad 2/3 transcription
    factors in the cytoplasm, inducing the expression of target genes such as α-SMA
    and COL1A1. Non-Smad pathways such as the MAPK/ERK, TAK1/JNK, PI3K/AKT pathways,
    can also be activated to promote cytoskeletal remodeling and β-catenin nuclear
    translocation during the process of EMT
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - FGF1
  - FGF2
  - FGF3
  - FGF4
  - FGF5
  - FGF6
  - FGF7
  - FGF8
  - FGF9
  - FGF10
  - FGF11
  - FGF12
  - FGF13
  - FGF14
  - FGF16
  - FGF17
  - FGF18
  - FGF19
  - FGF20
  - FGF21
  - FGF22
  - FGF23
  - AGTR2
  - PGR-AS1
  - TGFB1
  - TGFB2
  - TGFB3
  - EGF
  - ITK
  - SLC22A3
  - WNT1
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
  - ACTA1
  - TNF
  - SMAD2
  - SMAD3
  - MAPK1
  - MAPK3
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - EPHB2
  - IL6
  - MAP3K7
  - NR2C2
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - AKT1
  - AKT2
  - AKT3
  - SMAD4
  - CDH2
  - SNAI1
  - SNAI2
  - TWIST1
  - COL1A1
  - TNF-a
  - Fibronectin
---
